← Back to search
METHODIST HEALTHCARE MEMPHIS HOSPITALS
Doing business as METHODIST HEALTH SYSTEMS
MEMPHIS, TN, 38104
Unclaimed
Other Than Small Business
Subcontracting experience
3 records from government sources. Past participation is not evidence of current teaming interest.
| Role | Agency | Description | Vehicle | Obligated | Action date | Period |
|---|---|---|---|---|---|---|
| Subcontractor | Department of Health and Human Services | THE OVERALL OBJECTIVE OF THIS PROJECT IS TO PROVIDE DEFINITIVE EVIDENCE ON THE EFFECTIVENESS, SAFETY, AND MECHANISMS OF
LOW TITER GROUP O WHOLE BLOOD (LTOWB) AND TRANEXAMIC ACID (TXA) AS RESUSCITATION STRATEGIES FOR THE TREATMENT OF LIFETHREATENING BLEEDING SECONDARY TO TRAUMATIC INJURY IN CHILDREN. THE SCOPE OF WORK FOR THIS CONTRACT INCLUDES CLINICAL
ACTIVITIES (THE CONDUCT OF A MULTICENTER RANDOMIZED CLINICAL TRIAL IN CHILDREN) AS WELL AS RELATED REGULATORY ACTIVITIES
(OBTAINING IND FROM FDA FOR USE OF EXCEPTION TO INFORMED CONSENT (EFIC) THAT IS REQUIRED FOR THE CLINICAL TRIAL, AND
SINGLE IRB APPROVAL TO ENSURE ETHICAL AND APPROPRIATE CONDUCT OF THE CLINICAL TRIAL) AWD00008169-30 Parent award context Parent award agency: Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response Parent award NAICS: 541715 Parent award performance state: PA Parent award description: PROVIDE DEFINITIVE EVIDENCE ON THE EFFECTIVENESS, SAFETY, AND MECHANISMS OF LOW TITER GROUP O WHOLE BLOOD (LTOWB) AND TRANEXAMIC ACID (TXA) AS RESUSCITATION STRATEGIES FOR THE TREATMENT OF LIFE-THREATENING BLEEDING SECONDARY TO TRAUMATIC INJURY IN CH View parent award on USAspending | — | $211,611 | Jun 27, 2024 | — – — |
| Subcontractor | Department of Health and Human Services | THE OVERALL OBJECTIVE OF THIS PROJECT IS TO PROVIDE DEFINITIVE EVIDENCE ON THE EFFECTIVENESS, SAFETY, AND MECHANISMS OF
LOW TITER GROUP O WHOLE BLOOD (LTOWB) AND TRANEXAMIC ACID (TXA) AS RESUSCITATION STRATEGIES FOR THE TREATMENT OF LIFETHREATENING BLEEDING SECONDARY TO TRAUMATIC INJURY IN CHILDREN. THE SCOPE OF WORK FOR THIS CONTRACT INCLUDES CLINICAL
ACTIVITIES (THE CONDUCT OF A MULTICENTER RANDOMIZED CLINICAL TRIAL IN CHILDREN) AS WELL AS RELATED REGULATORY ACTIVITIES
(OBTAINING IND FROM FDA FOR USE OF EXCEPTION TO INFORMED CONSENT (EFIC) THAT IS REQUIRED FOR THE CLINICAL TRIAL, AND
SINGLE IRB APPROVAL TO ENSURE ETHICAL AND APPROPRIATE CONDUCT OF THE CLINICAL TRIAL) AWD00008169-30 Parent award context Parent award agency: Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response Parent award NAICS: 541715 Parent award performance state: PA Parent award description: PROVIDE DEFINITIVE EVIDENCE ON THE EFFECTIVENESS, SAFETY, AND MECHANISMS OF LOW TITER GROUP O WHOLE BLOOD (LTOWB) AND TRANEXAMIC ACID (TXA) AS RESUSCITATION STRATEGIES FOR THE TREATMENT OF LIFE-THREATENING BLEEDING SECONDARY TO TRAUMATIC INJURY IN CH View parent award on USAspending | — | $211,611 | Jun 27, 2024 | — – — |
| Subcontractor | Department of Health and Human Services | THE OVERALL OBJECTIVE OF THIS PROJECT IS TO PROVIDE DEFINITIVE EVIDENCE ON THE EFFECTIVENESS, SAFETY, AND MECHANISMS OF
LOW TITER GROUP O WHOLE BLOOD (LTOWB) AND TRANEXAMIC ACID (TXA) AS RESUSCITATION STRATEGIES FOR THE TREATMENT OF LIFETHREATENING BLEEDING SECONDARY TO TRAUMATIC INJURY IN CHILDREN. THE SCOPE OF WORK FOR THIS CONTRACT INCLUDES CLINICAL
ACTIVITIES (THE CONDUCT OF A MULTICENTER RANDOMIZED CLINICAL TRIAL IN CHILDREN) AS WELL AS RELATED REGULATORY ACTIVITIES
(OBTAINING IND FROM FDA FOR USE OF EXCEPTION TO INFORMED CONSENT (EFIC) THAT IS REQUIRED FOR THE CLINICAL TRIAL, AND
SINGLE IRB APPROVAL TO ENSURE ETHICAL AND APPROPRIATE CONDUCT OF THE CLINICAL TRIAL) AWD00008169-30 Parent award context Parent award agency: Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response Parent award NAICS: 541715 Parent award performance state: PA Parent award description: PROVIDE DEFINITIVE EVIDENCE ON THE EFFECTIVENESS, SAFETY, AND MECHANISMS OF LOW TITER GROUP O WHOLE BLOOD (LTOWB) AND TRANEXAMIC ACID (TXA) AS RESUSCITATION STRATEGIES FOR THE TREATMENT OF LIFE-THREATENING BLEEDING SECONDARY TO TRAUMATIC INJURY IN CH View parent award on USAspending | — | $211,611 | Jun 27, 2024 | — – — |
Contract vehicles are shown only when present in the source record. Linked award numbers and vehicles open the authoritative record on USAspending.gov.